TMPRSS3 Polyclonal Antibody

货号：ES3619
价格：面议
点击：2279

产品介绍

抗体信息

应用	WB;IHC-p;IF/ICC;ELISA
反应种属	Human;Mouse
别称	TMPRSS3; ECHOS1; TADG12; Transmembrane protease serine 3; Serine protease TADG-12; Tumor-associated differentially-expressed gene 12 protein

【仅供科学研究使用】

相关产品:

产品名称	点击数
Anti-Daclizumab Neutralizing Recombinant Antibody \|抗达克珠单抗中和重组抗体(靶标：达克珠单抗中和抗体)	483
Anti-Daclizumab Neutralizing Recombinant Antibody \|抗达克珠单抗中和重组抗体(靶标：达克珠单抗中和抗体)	604
Anti-Daclizumab Neutralizing Recombinant Antibody \|抗达克珠单抗中和重组抗体(靶标：达克珠单抗中和抗体)	425
Anti-Daclizumab Neutralizing Recombinant Antibody \|抗达克珠单抗中和重组抗体(靶标：达克珠单抗中和抗体)	570
Anti-Atibuclimab Neutralizing Recombinant Antibody \|抗阿替布利单抗中和重组抗体(靶标：阿替布利单抗中和抗体)	436
Anti-Atibuclimab Neutralizing Recombinant Antibody \|抗阿替布利单抗中和重组抗体(靶标：阿替布利单抗中和抗体)	524
Anti-Atibuclimab Neutralizing Recombinant Antibody \|抗阿替布利单抗中和重组抗体(靶标：阿替布利单抗中和抗体)	275
Anti-Atibuclimab Neutralizing Recombinant Antibody \|抗阿替布利单抗中和重组抗体(靶标：阿替布利单抗中和抗体)	340
Anti-Secukinumab Neutralizing Recombinant Antibody \|抗司库奇尤单抗中和重组抗体(靶标：司库奇尤单抗中和抗体)	312
Anti-Secukinumab Neutralizing Recombinant Antibody \|抗司库奇尤单抗中和重组抗体(靶标：司库奇尤单抗中和抗体)	519
Anti-Secukinumab Neutralizing Recombinant Antibody \|抗司库奇尤单抗中和重组抗体(靶标：司库奇尤单抗中和抗体)	635
Anti-Secukinumab Neutralizing Recombinant Antibody \|抗司库奇尤单抗中和重组抗体(靶标：司库奇尤单抗中和抗体)	441
Anti-Enfortumab Neutralizing Recombinant Antibody \|抗恩福妥单抗中和重组抗体(靶标：恩福妥单抗中和抗体)	413
Anti-Enfortumab Neutralizing Recombinant Antibody \|抗恩福妥单抗中和重组抗体(靶标：恩福妥单抗中和抗体)	627
Anti-Enfortumab Neutralizing Recombinant Antibody \|抗恩福妥单抗中和重组抗体(靶标：恩福妥单抗中和抗体)	649
Anti-Enfortumab Neutralizing Recombinant Antibody \|抗恩福妥单抗中和重组抗体(靶标：恩福妥单抗中和抗体)	480
Anti-Certolizumab Non-Neutralizing Recombinant Antibody \|抗赛妥珠单抗非中和重组抗体(靶标：赛妥珠单抗非中和抗体)	331
Anti-Certolizumab Non-Neutralizing Recombinant Antibody \|抗赛妥珠单抗非中和重组抗体(靶标：赛妥珠单抗非中和抗体)	632
Anti-Certolizumab Non-Neutralizing Recombinant Antibody \|抗赛妥珠单抗非中和重组抗体(靶标：赛妥珠单抗非中和抗体)	506
Anti-Certolizumab Neutralizing Recombinant Antibody \|抗赛妥珠单抗中和重组抗体(靶标：赛妥珠单抗中和抗体)	317

在线客服

QQ交谈

销售热线：
15898894496(同微信)
我要留言
周一至周五每天9:00-17:00